Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
J Cereb Blood Flow Metab. 2024 Nov;44(11):1253-1261. doi: 10.1177/0271678X241261771. Epub 2024 Jun 17.
Peak width of skeletonized mean diffusivity (PSMD) is an emerging diffusion-MRI based marker to study subtle early alterations to white matter microstructure. We assessed PSMD over the clinical continuum in Dutch-type hereditary CAA (D-CAA) and its association with other CAA-related MRI-markers and cognitive symptoms. We included (pre)symptomatic D-CAA mutation-carriers and calculated PSMD from diffusion-MRI data. Associations between PSMD-levels, cognitive performance and CAA-related MRI-markers were assessed with linear regression models. We included 59 participants (25/34 presymptomatic/symptomatic; mean age 39/58 y). PSMD-levels increased with disease severity and were higher in symptomatic D-CAA mutation-carriers (median [range] 4.90 [2.77-9.50]mm/s × 10) compared with presymptomatic mutation-carriers (2.62 [1.96-3.43]mm/s × 10) p = <0.001. PSMD was positively correlated with age, CAA-SVD burden on MRI (adj.B [confidence interval] = 0.42 [0.16-0.67], p = 0.002), with number of cerebral microbleeds (adj.B = 0.30 [0.08-0.53], p = 0.009), and with both deep (adj.B = 0.46 [0.22-0.69], p = <0.001) and periventricular (adj.B = 0.38 [0.13-0.62], p = 0.004) white matter hyperintensities. Increasing PSMD was associated with decreasing Trail Making Test (TMT)-A performance (B = -0.42 [-0.69-0.14], p = 0.04. In D-CAA mutation-carriers microstructural white matter damage is associated with disease phase, CAA burden on MRI and cognitive impairment as reflected by a decrease in information processing speed. PSMD, as a global measure of alterations to the white matter microstructure, may be a useful tool to monitor disease progression in CAA.
骨架化平均弥散度峰值(PSMD)是一种新兴的基于弥散磁共振成像的标志物,用于研究脑白质微观结构的早期细微改变。我们评估了荷兰型遗传性脑淀粉样血管病(D-CAA)的临床连续体中的 PSMD,并评估了其与其他 CAA 相关的 MRI 标志物和认知症状的关系。我们纳入了(前)症状性 D-CAA 突变携带者,并从弥散磁共振成像数据中计算出 PSMD。使用线性回归模型评估 PSMD 水平、认知表现和 CAA 相关 MRI 标志物之间的关系。我们纳入了 59 名参与者(25/34 名无症状/有症状;平均年龄 39/58 岁)。PSMD 水平随疾病严重程度而增加,且在有症状的 D-CAA 突变携带者中更高(中位数[范围]4.90[2.77-9.50]mm/s×10)与无症状突变携带者相比(2.62[1.96-3.43]mm/s×10)p<0.001。PSMD 与年龄呈正相关,与 MRI 上的 CAA-SVD 负担呈正相关(调整后的 B [置信区间]为 0.42[0.16-0.67],p=0.002),与脑微出血数量呈正相关(调整后的 B 为 0.30[0.08-0.53],p=0.009),与深部(调整后的 B 为 0.46[0.22-0.69],p<0.001)和脑室周围(调整后的 B 为 0.38[0.13-0.62],p=0.004)脑白质高信号均呈正相关。PSMD 升高与 Trail Making Test(TMT)-A 表现下降相关(B=-0.42[-0.69-0.14],p=0.04)。在 D-CAA 突变携带者中,微观结构脑白质损伤与疾病阶段、MRI 上的 CAA 负担以及认知障碍有关,表现为信息处理速度下降。PSMD 作为脑白质微观结构改变的整体测量指标,可能是监测 CAA 疾病进展的有用工具。